Skip to main content
Premium Trial:

Request an Annual Quote

Abbott's Q3 MDx Sales Rise 15 Percent

NEW YORK (GenomeWeb News) – Abbott today reported that its third quarter revenues increased 2 percent year over year, with a decline in pharmaceuticals sales offset by gains in its diagnostics business.

Overall, the firm reported sales of $5.37 billion, up from $5.27 million for the third quarter of 2012. Abbott's Nutrition and Medical Devices businesses both reported 2 percent revenue gains year over year, while Pharmaceuticals fell 3 percent. Its Diagnostics business, however, reported sales growth of 8 percent.

Abbott's molecular diagnostics business reported 15 percent sales growth to $117 million for the quarter, up from $102 million in Q3 2012. Its point-of-care Dx business jumped nearly 17 percent to $100 million, while its core laboratory Dx sales were up 6 percent to $908 million.

Abbott said that the MDx sales were driven by "strong infectious disease growth, particularly in emerging markets due to the impact of recent tenders, as well as the continued growth of companion diagnostics."

The firm posted net earnings of $966 million, or $.55 per shares from continuing operations, compared to $1.94 billion, or $.42 per share from continuing operations, in Q3 last year.

Abbott expects to report FY 2013 EPS between $1.98 and $2.04.

Shares of Abbott were up 6 percent at $35.65 in Wednesday morning trade on the New York Stock Exchange.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.